. .. Epidémiologie,

.. .. Données,

.. .. Critères,

.. .. Données,

.. .. Diagnostics,

.. .. Les,

?. .. Alternatives,

I. V. Histoire and .. .. Et-pronostic,

. .. Réponse-thérapeutique-initiale,

. Profils-thérapeutiques-À-moyen and .. .. Long-terme,

E. .. Données,

.. .. Facteurs,

. Ii and . .. Methods,

. Ii, Facteurs pronostiques : étude de la littérature et comparaison avec notre étude, p.49

A. .. ,

B. .. ,

, Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-first revision, Joint Task Force of the EFNS and the PNS, vol.15, pp.295-301, 2010.

A. Uncini, K. Susuki, and Y. N. , Nodo-paranodopathy: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies, Clin Neurophysiol, vol.124, issue.10, pp.1928-1962, 2013.

E. A. Cats, W. Pol, . Van-der, S. Piepers, H. Franssen et al., Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy, Neurology, vol.75, issue.9, pp.818-843, 2010.

J. Léger, K. Viala, F. Cancalon, T. Maisonobe, B. Gruwez et al., Intravenous immunoglobulin as short-and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients, Neurosurgery & Psychiatry, vol.79, issue.1, pp.93-99, 2008.

L. H. Van-den-berg, H. Franssen, and J. H. Wokke, The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy, Brain, vol.121, pp.421-429, 1998.

A. Pestronk, J. Florence, T. Miller, R. Choksi, M. Al-lozi et al., Treatment of IgM antibody associated polyneuropathies using rituximab, J Neurol Neurosurg Psychiatry, vol.74, issue.4, pp.485-494, 2003.

V. Chaudhry and D. R. Cornblath, An open-label trial of rituximab (Rituxan®) in multifocal motor neuropathy, J Peripher Nerv Syst, vol.15, issue.3, pp.196-201, 2010.

A. Michaud, E. Delmont, P. Jeandel, and C. Desnuelle, Amélioration d'un cas de neuropathie motrice multifocale avec blocs de conduction sévère, 2011.

K. Stieglbauer, R. Topakian, G. Hinterberger, and F. T. Aichner, Beneficial effect of rituximab monotherapy in multifocal motor neuropathy, Neuromuscul Disord, 2009.

L. Vlam, W. Van-der-pol, E. A. Cats, D. C. Straver, S. Piepers et al., Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies, Nat Rev Neurol, vol.8, issue.1, pp.48-58, 2012.
DOI : 10.1038/nrneurol.2011.175

T. Umapathi, R. Hughes, E. Nobile-orazio, and J. Léger, Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy. Cochrane Database Syst Rev, p.3217, 2015.
DOI : 10.1002/14651858.cd003217.pub4

URL : https://air.unimi.it/bitstream/2434/288120/2/60791e4af428afc4498c9a8ae074631db85ea30ffe9897f4e2a2b103bfd20f2d.pdf

F. Eftimov and V. Schaik, Immunotherapy of multifocal motor neuropathy, Expert Opin Biol Ther, vol.11, issue.3, pp.329-371, 2011.
DOI : 10.1517/14712598.2011.548798

M. Jinka and V. Chaudhry, Treatment of multifocal motor neuropathy, Curr Treat Options Neurol, vol.16, issue.2, p.269, 2014.

J. Van-asseldonk, L. H. Van-den-berg, S. Kalmijn, R. M. Van-den-berg-vos, C. H. Polman et al., Axon loss is an important determinant of weakness in multifocal motor neuropathy, J Neurol Neurosurg Psychiatry, vol.77, issue.6, pp.743-750, 2006.

J. P. Azulay, P. Rihet, J. Pouget, F. Cador, O. Blin et al., Long term follow up of multifocal motor neuropathy with conduction block under treatment, J Neurol Neurosurg Psychiatry, vol.62, issue.4, pp.391-395, 1997.

R. M. Van-den-berg-vos, H. Franssen, J. Wokke, H. W. Van-es, . Van-den et al., Multifocal motor neuropathy: Diagnostic criteria that predict the response to immunoglobulin treatment, Ann Neurol, vol.48, issue.6, pp.919-945, 2000.

E. Nobile-orazio, A. Cappellari, N. Meucci, M. Carpo, F. Terenghi et al., Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block, J Neurol Neurosurg Psychiatry, vol.72, issue.6, pp.761-767, 2002.

M. Stangel, R. Gold, D. Pittrow, U. Baumann, M. Borte et al., Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registry, Ther Adv Neurol Disord, vol.9, issue.3, pp.165-79, 2016.

E. Nobile-orazio, Multifocal motor neuropathy, J Neuroimmunol, vol.115, issue.12, pp.4-18, 2001.

F. Terenghi, A. Cappellari, A. Bersano, M. Carpo, S. Barbieri et al., How long is IVIg effective in multifocal motor neuropathy? Neurology, vol.62, pp.666-674, 2004.

E. K. Vanhoutte, C. G. Faber, and I. Merkies, ENMC international workshop: Outcome measures in inflammatory peripheral neuropathies 8-10, vol.23, pp.924-957, 2013.

K. C. Gorson, V. Schaik, I. N. Merkies, I. Lewis, R. A. Barohn et al., Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice, J Peripher Nerv Syst, vol.15, issue.4, pp.326-359, 2010.

Y. A. Rajabally, J. Cassereau, A. Robbe, and G. Nicolas, Disease status in chronic inflammatory demyelinating polyneuropathy: inter-centre comparative analysis and correlates, Eur J Neurol, vol.22, issue.11, pp.1469-73, 2015.

M. Pruppers, T. Draak, E. K. Vanhoutte, W. Van-der-pol, K. C. Gorson et al., Outcome measures in MMN revisited: further improvement needed, J Peripher Nerv Syst, vol.20, issue.3, pp.306-324, 2015.

E. A. Cats, B. C. Jacobs, Y. N. Tio-gillen, A. P. Piepers, S. Franssen et al., Multifocal motor neuropathy Association of anti-GM1 IgM antibodies with clinical features, Neurology, vol.75, issue.22, pp.1961-1968, 2010.

, Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-first revision, Joint Task Force of the EFNS and the PNS, vol.15, pp.295-301, 2010.

A. Uncini, K. Susuki, and Y. N. , Nodo-paranodopathy: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies, Clin Neurophysiol. oct, vol.124, issue.10, pp.1928-1962, 2013.

E. A. Cats, . Van-der-w-l, S. Piepers, H. Franssen, B. C. Jacobs et al., Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy, Neurology. 31 août, vol.75, issue.9, pp.818-843, 2010.

J. Léger, K. Viala, F. Cancalon, T. Maisonobe, B. Gruwez et al., Intravenous immunoglobulin as short-and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients, Neurosurgery & Psychiatry. 1 janv, vol.79, issue.1, pp.93-99, 2008.

K. Stieglbauer, R. Topakian, G. Hinterberger, and F. T. Aichner, Beneficial effect of rituximab monotherapy in multifocal motor neuropathy, Neuromuscul Disord. juill, vol.19, issue.7, pp.473-478, 2009.

A. Pestronk, J. Florence, T. Miller, R. Choksi, M. Al-lozi et al., Treatment of IgM antibody associated polyneuropathies using rituximab, J Neurol Neurosurg Psychiatry. avr, vol.74, issue.4, pp.485-494, 2003.

V. Chaudhry and D. R. Cornblath, An open-label trial of rituximab (Rituxan®) in multifocal motor neuropathy, J Peripher Nerv Syst. sept, vol.15, issue.3, pp.196-201, 2010.

F. Eftimov and V. Schaik, Immunotherapy of multifocal motor neuropathy, Expert Opin Biol Ther. mars, vol.11, issue.3, pp.329-371, 2011.

T. Umapathi, R. Hughes, E. Nobile-orazio, and J. Léger, Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy, Cochrane Database Syst Rev. mars, issue.3, p.3217, 2015.

L. Vlam, W. Van-der-pol, E. A. Cats, D. C. Straver, S. Piepers et al., Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies, Nat Rev Neurol. janv, vol.8, issue.1, pp.48-58, 2012.

M. Jinka and V. Chaudhry, Treatment of multifocal motor neuropathy, Curr Treat Options Neurol. févr, vol.16, issue.2, p.269, 2014.

G. Roth, J. Rohr, M. R. Magistris, and F. Ochsner, Motor neuropathy with proximal multifocal persistent conduction block, fasciculations and myokymia. Evolution to tetraplegia, Eur Neurol, vol.25, issue.6, pp.416-439, 1986.
DOI : 10.1159/000116045

D. A. Chad, K. Hammer, and J. Sargent, Slow resolution of multifocal weakness and fasciculation: a reversible motor neuron syndrome, Neurology. sept, vol.36, issue.9, pp.1260-1263, 1986.

G. J. Parry and S. Clarke, Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease, Muscle Nerve. févr, vol.11, issue.2, pp.103-110, 1988.
DOI : 10.1002/mus.880110203

A. Pestronk, D. R. Cornblath, A. A. Ilyas, H. Baba, R. H. Quarles et al., A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside, Ann Neurol. juill, vol.24, issue.1, pp.73-81, 1988.

G. Nicolas, Conduite à tenir devant une neuropathie démyélinisante

R. Kaji, Physiology of conduction block in multifocal motor neuropathy and other demyelinating neuropathies, Muscle Nerve. mars, vol.27, issue.3, pp.285-96, 2003.

A. Uncini and J. Vallat, Autoimmune nodo-paranodopathies of peripheral nerve: the concept is gaining ground, J Neurol Neurosurg Psychiatry. 16 déc, 2017.

M. C. Kiernan, J. Guglielmi, R. Kaji, N. Murray, and H. Bostock, Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block, Brain. mars, vol.125, issue.3, pp.664-75, 2002.

G. Guillain, J. A. Barré, and A. Strohl, Radiculoneuritis syndrome with hyperalbuminosis of cerebrospinal fluid without cellular reaction. Notes on clinical features and graphs of tendon reflexes, Ann Med Interne, vol.150, issue.1, pp.24-32, 1916.

K. Susuki, H. Baba, K. Tohyama, K. Kanai, S. Kuwabara et al., Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers, Glia. mai, vol.55, issue.7, pp.746-57, 2007.

I. Illa, N. Ortiz, E. Gallard, C. Juarez, J. M. Grau et al., Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides, Ann Neurol. août, vol.38, issue.2, pp.218-242, 1995.

N. Yuki, M. Yamada, M. Koga, M. Odaka, K. Susuki et al., Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside, Ann Neurol. juin, vol.49, issue.6, pp.712-732, 2001.

M. Santoro, A. Uncini, M. Corbo, S. M. Staugaitis, F. P. Thomas et al., Experimental conduction block induced by serum from a patient with anti-GM1 antibodies, Ann Neurol. avr, vol.31, issue.4, pp.385-90, 1992.

A. Uncini, M. Santoro, M. Corbo, A. Lugaresi, and N. Latov, Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies, Muscle Nerve. juin, vol.16, issue.6, pp.610-615, 1993.

N. Yuki, H. Watanabe, T. Nakajima, and P. J. Späth, IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy, J Neurol Neurosurg Psychiatr. janv, vol.82, issue.1, pp.87-91, 2011.

K. Susuki, M. N. Rasband, K. Tohyama, K. Koibuchi, S. Okamoto et al., Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers, J Neurosci. 11 avr, vol.27, issue.15, pp.3956-67, 2007.

C. Rosier and J. P. Camdessanché, Les nodo-paranodopathies, un concept en plein essor, Pratique Neurologique-FMC. 1 févr, vol.9, issue.1, pp.31-36, 2018.
DOI : 10.1016/j.praneu.2017.10.002

L. Querol, G. Nogales-gadea, R. Rojas-garcia, J. Diaz-manera, J. Pardo et al., Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg, Neurology. 11 mars, vol.82, issue.10, pp.879-86, 2014.

J. Vallat, Y. N. Sekiguchi, K. Kokubun, N. Oka, N. Mathis et al., Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies, Neuromuscul Disord. mars, vol.27, issue.3, pp.290-293, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01474310

P. Charles, S. Tait, C. Faivre-sarrailh, G. Barbin, F. Gunn-moore et al., Neurofascin is a glial receptor for the paranodin/Caspr-contactin axonal complex at the axoglial junction, Curr Biol. 5 févr, vol.12, issue.3, pp.217-237, 2002.

F. Notturno, D. Febo, T. , Y. N. , F. Rodriguez et al., Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy, J Neuroimmunol, vol.15, issue.1-2, pp.207-219, 2014.

K. Doppler, L. Appeltshauser, H. H. Krämer, J. Ng, E. Meinl et al., Contactin-1 and Neurofascin-155/-186 Are Not Targets of Auto-Antibodies in Multifocal Motor Neuropathy, PLoS ONE, vol.10, issue.7, p.134274, 2015.

R. Kaji, N. Oka, T. Tsuji, T. Mezaki, T. Nishio et al., Pathological findings at the site of conduction block in multifocal motor neuropathy, Ann Neurol. févr, vol.33, issue.2, pp.152-160, 1993.

B. V. Taylor, P. Dyck, J. Engelstad, G. Gruener, I. Grant et al., Multifocal motor neuropathy: pathologic alterations at the site of conduction block, J Neuropathol Exp Neurol. févr, vol.63, issue.2, pp.129-166, 2004.

A. M. Corse, V. Chaudhry, T. O. Crawford, D. R. Cornblath, R. W. Kuncl et al., Sensory nerve pathology in multifocal motor neuropathy, Ann Neurol. mars, vol.39, issue.3, pp.319-344, 1996.

J. G. Mcleod, J. D. Pollard, P. Macaskill, M. A. Spring, P. Khurana et al., Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol. déc, vol.46, issue.6, pp.910-913, 1999.

M. Türk, I. Weber, G. Vogt-ladner, R. Schröder, and M. Winterholler, Diaphragmatic dysfunction as the presenting symptom in neuromuscular disorders: A retrospective longitudinal study of etiology and outcome in 30 German patients. Neuromuscular Disorders, vol.9, 2018.

J. Van-asseldonk, L. H. Van-den-berg, R. M. Van-den-berg-vos, G. H. Wieneke, J. Wokke et al., Demyelination and axonal loss in multifocal motor neuropathy: distribution and relation to weakness, Brain. 1 janv, vol.126, issue.1, pp.186-98, 2003.

S. Attarian, J. Azulay, A. Verschueren, and J. Pouget, Magnetic stimulation using a triplestimulation technique in patients with multifocal neuropathy without conduction block, Muscle Nerve. déc, vol.32, issue.6, pp.710-714, 2005.

N. Deroide, D. Uzenot, A. Verschueren, J. Azulay, J. Pouget et al., Triple-stimulation technique in multifocal neuropathy with conduction block, Muscle Nerve. mai, vol.35, issue.5, pp.632-638, 2007.

V. Chaudhry and M. Swash, Multifocal motor neuropathy: is conduction block essential?, Neurology. 22 août, vol.67, issue.4, pp.558-567, 2006.

I. Lievens, E. Fournier, K. Viala, T. Maisonobe, P. Bouche et al., Multifocal motor neuropathy: a retrospective study of sensory nerve conduction velocities in long-term follow-up of 21 patients, Rev Neurol, vol.165, issue.3, pp.243-251, 2009.

V. Lambrecq, E. Krim, M. Rouanet-larrivière, and A. Lagueny, Sensory loss in multifocal motor neuropathy: a clinical and electrophysiological study, Muscle Nerve. févr, vol.39, issue.2, pp.131-137, 2009.

J. Van-asseldonk, L. H. Van-den-berg, S. Kalmijn, R. M. Van-den-berg-vos, C. H. Polman et al., Axon loss is an important determinant of weakness in multifocal motor neuropathy, J Neurol Neurosurg Psychiatry. juin, vol.77, issue.6, pp.743-750, 2006.

N. Garg, J. Howells, C. Yiannikas, S. Vucic, A. V. Krishnan et al., Motor unit remodelling in multifocal motor neuropathy: The importance of axonal loss, Clin Neurophysiol, vol.128, issue.10, pp.2022-2030, 2017.

A. B. Jacobsen, H. Bostock, A. Fuglsang-frederiksen, L. Duez, S. Beniczky et al., Reproducibility, and sensitivity to motor unit loss in amyotrophic lateral sclerosis, of a novel MUNE method: MScanFit MUNE, Clin Neurophysiol. juill, vol.128, issue.7, pp.1380-1388, 2017.

F. Terenghi, A. Cappellari, A. Bersano, M. Carpo, S. Barbieri et al., How long is IVIg effective in multifocal motor neuropathy?, Neurology. 24 févr, vol.62, issue.4, pp.666-674, 2004.

R. M. Van-den-berg-vos, H. Franssen, J. Wokke, and L. H. Van-den-berg, Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment, Brain. 1 août, vol.125, issue.8, pp.1875-86, 2002.

H. W. Van-es, L. H. Van-den-berg, H. Franssen, T. D. Witkamp, L. M. Ramos et al., Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy, Neurology. mai, vol.48, issue.5, pp.1218-1242, 1997.

I. Basta, A. Nikolid, S. Apostolski, S. Lavrnid, T. Stosid-opindal et al., Diagnostic value of combined magnetic resonance imaging examination of brachial plexus and electrophysiological studies in multifocal motor neuropathy, Vojnosanit Pregl. août, vol.71, issue.8, pp.723-732, 2014.

A. Grimm, B. F. Décard, I. Athanasopoulou, K. Schweikert, M. Sinnreich et al., Nerve ultrasound for differentiation between amyotrophic lateral sclerosis and multifocal motor neuropathy, J Neurol, vol.262, issue.4, pp.870-80, 2015.

E. Nobile-orazio, Multifocal motor neuropathy, J Neuroimmunol. avr, vol.115, issue.1-2, pp.4-18, 2001.

E. Nobile-orazio, C. Giannotta, L. Musset, P. Messina, and J. Léger, Sensitivity and predictive value of anti-GM1/galactocerebroside IgM antibodies in multifocal motor neuropathy, JNeurol Neurosurg Psychiatr. juill, vol.85, issue.7, pp.754-762, 2014.

E. A. Cats, W. Van-der-pol, A. P. Tio-gillen, F. P. Diekstra, L. H. Van-den-berg et al., Clonality of anti-GM1 IgM antibodies in multifocal motor neuropathy and the GuillainBarré syndrome, J Neurol Neurosurg Psychiatr. mai, vol.86, issue.5, pp.502-506, 2015.

J. M. Léger, B. Chassande, L. Musset, V. Meininger, P. Bouche et al., Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebocontrolled study, Brain. janv, vol.124, issue.1, pp.145-53, 2001.

I. N. Van-schaik, L. H. Van-den-berg, R. Haan, and M. Vermeulen, Intravenous immunoglobulin for multifocal motor neuropathy. Cochrane Database Syst Rev, avr, vol.18, issue.2, p.4429, 2005.

E. K. Vanhoutte, C. G. Faber, and I. Merkies, ENMC international workshop: Outcome measures in inflammatory peripheral neuropathies 8-10, vol.23, pp.924-957, 2013.

E. K. Vanhoutte, C. G. Faber, S. I. Van-nes, E. A. Cats, W. Van-der-pol et al., Raschbuilt Overall Disability Scale for Multifocal motor neuropathy (MMN-RODS), J Peripher Nerv Syst, vol.20, pp.296-305, 2015.

A. Tennant and P. G. Conaghan, The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper?, Arthritis Rheum. 15 déc, vol.57, issue.8, pp.1358-62, 2007.

I. Merkies and G. Lauria, 131st ENMC international workshop: selection of outcome measures for peripheral neuropathy clinical trials 10-12, Neuromuscul Disord. févr, vol.16, issue.2, pp.149-56, 2004.

D. Carvalho, M. Dengler, R. Eisen, A. England, J. D. Kaji et al., Electrodiagnostic criteria for diagnosis of ALS, Clin Neurophysiol. mars, vol.119, issue.3, pp.497-503, 2008.

S. Yamashita and Y. Ando, Genotype-phenotype relationship in hereditary amyotrophic lateral sclerosis, Transl Neurodegener, vol.4, p.13, 2015.

P. Devic and P. Petiot, Distal hereditary motor neuropathy, Rev Neurol, vol.167, issue.11, pp.781-90, 2011.

Y. Huang, C. Chen, and . Hirayama-disease, Neuroimaging Clin N Am, vol.21, issue.4, pp.939-50, 2011.

K. Viala, L. Renié, T. Maisonobe, A. Béhin, J. Neil et al., Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome, Brain. sept, vol.127, pp.2010-2017, 2004.

A. Verschueren, J. P. Azulay, S. Attarian, J. Boucraut, J. F. Pellissier et al., Lewis-Sumner syndrome and multifocal motor neuropathy, Muscle Nerve. janv, vol.31, issue.1, pp.88-94, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00094136

J. P. Azulay, O. Blin, J. Pouget, J. Boucraut, F. Billé-turc et al., Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study, Neurology. mars, vol.44, issue.3, pp.429-461, 1994.

H. Kerkhoff, P. L. Oey, H. Franssen, M. I. Vermeulen, M. Jennekens et al., Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study, Neurosurgery & Psychiatry. 1 sept, vol.59, issue.3, pp.248-52, 1995.

P. Federico, D. W. Zochodne, A. F. Hahn, W. F. Brown, and T. E. Feasby, Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study, Neurology, vol.55, issue.9, pp.1256-62, 2000.

A. F. Hahn, S. R. Beydoun, V. Lawson, . Team, M. Oh et al., A controlled trial of intravenous immunoglobulin in multifocal motor neuropathy, J Peripher Nerv Syst. 1 déc, vol.18, issue.4, pp.321-351, 2013.

E. Delmont, J. P. Azulay, D. Uzenot, S. Attarian, A. Verschueren et al., Neuropathies motrices multifocales avec blocs de conduction, profil évolutif sous immunoglobulines intraveineuses, Revue Neurologique. janv, vol.163, issue.1, pp.82-90, 2007.

D. Cocito, A. Merola, E. Peci, A. Mazzeo, R. Fazio et al., Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study, J Neurol, vol.261, issue.11, pp.2159-64, 2014.

P. A. Van-doorn and I. Merkies, How to assess new drugs for neuropathies: advances in trial design and methodology, Curr Opin Neurol, vol.21, issue.5, pp.519-545, 2008.

A. Michaud, E. Delmont, P. Jeandel, and C. Desnuelle, Amélioration d'un cas de neuropathie motrice multifocale avec blocs de conduction sévère, dépendant des immunoglobulines intraveineuses, après adjonction de rituximab au long cours, Revue Neurologique. déc, vol.167, issue.12, pp.916-936, 2011.

C. Krarup, J. D. Stewart, A. J. Sumner, A. Pestronk, and S. A. Lipton, A syndrome of asymmetric limb weakness with motor conduction block, Neurology. janv, vol.40, issue.1, pp.118-145, 1990.

P. Bouche, A. Moulonguet, A. B. Younes-chennoufi, D. Adams, N. Baumann et al., Multifocal motor neuropathy with conduction block: a study of 24 patients, J Neurol Neurosurg Psychiatry. juill, vol.59, issue.1, pp.38-44, 1995.

I. S. Martina, P. A. Van-doorn, P. I. Schmitz, J. Meulstee, and F. G. Van-der-meché, Chronic motor neuropathies: response to interferon-beta1a after failure of conventional therapies, J Neurol Neurosurg Psychiatry. févr, vol.66, issue.2, pp.197-201, 1999.

R. M. Van-den-berg-vos, L. H. Van-den-berg, H. Franssen, P. A. Van-doorn, I. S. Merkies et al., Treatment of multifocal motor neuropathy with interferon-beta1A, Neurology. 11 avr, vol.54, issue.7, pp.1518-1539, 2000.

E. Nobile-orazio, F. Terenghi, D. Cocito, F. Gallia, and C. Casellato, Oral methotrexate as adjunctive therapy in patients with multifocal motor neuropathy on chronic IVIg therapy, J Peripher Nerv Syst. sept, vol.14, issue.3, pp.203-208, 2009.

R. Nemni, G. Santuccio, E. Calabrese, G. Galardi, and N. Canal, Efficacy of cyclosporine treatment in multifocal motor neuropathy, J Neurol. sept, vol.250, issue.9, pp.1118-1138, 2003.

A. M. Fitzpatrick, C. A. Mann, S. Barry, K. Brennan, J. R. Overell et al., An open label clinical trial of complement inhibition in multifocal motor neuropathy, J Peripher Nerv Syst. juin, vol.16, issue.2, pp.84-91, 2011.

S. Piepers, R. Van-den-berg-vos, W. Van-der-pol, H. Franssen, and J. Wokke, Van den Berg L. Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial, Brain. août, vol.130, issue.8, pp.2004-2014, 2007.

A. Pestronk, V. Chaudhry, E. L. Feldman, J. W. Griffin, D. R. Cornblath et al., Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies, Ann Neurol. mars, vol.27, issue.3, pp.316-342, 1990.

A. O. Bayrak, H. Ulusoy, N. Bolat, B. Do?an, and T. Ozbenli, Multifocal Motor Neuropathy Associated With Infliximab: A Case Report and a Literature Review, Neurologist. juill, vol.22, issue.4, pp.144-150, 2017.

, European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-First Revision, Journal of the Peripheral Nervous System. 1 mars, vol.15, issue.1, pp.1-9, 2010.

L. Querol, R. Rojas-garcía, J. Diaz-manera, J. Barcena, J. Pardo et al., Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins. Neurol Neuroimmunol Neuroinflamm, vol.2, p.149, 2015.

M. Stangel, R. Gold, D. Pittrow, U. Baumann, M. Borte et al., Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registry, Ther Adv Neurol Disord. mai, vol.9, issue.3, pp.165-79, 2016.

S. Vucic, K. R. Black, P. Chong, and D. Cros, Multifocal motor neuropathy: decrease in conduction blocks and reinnervation with long-term IVIg, Neurology, vol.12, issue.7, pp.1264-1273, 2004.

E. A. Cats, B. C. Jacobs, Y. N. Tio-gillen, A. P. Piepers, S. Franssen et al., Multifocal motor neuropathy Association of anti-GM1 IgM antibodies with clinical features, Neurology, vol.75, issue.22, pp.1961-1968, 2010.

E. Nobile-orazio, A. Cappellari, N. Meucci, M. Carpo, F. Terenghi et al., Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block, J Neurol Neurosurg Psychiatry. juin, vol.72, issue.6, pp.761-767, 2002.

M. Pruppers, T. Draak, E. K. Vanhoutte, W. Van-der-pol, K. C. Gorson et al., Outcome measures in MMN revisited: further improvement needed, J Peripher Nerv Syst. sept, vol.20, issue.3, pp.306-324, 2015.

J. P. Azulay, P. Rihet, J. Pouget, F. Cador, O. Blin et al., Long term follow up of multifocal motor neuropathy with conduction block under treatment, J Neurol Neurosurg Psychiatry. avr, vol.62, issue.4, pp.391-395, 1997.

R. M. Van-den-berg-vos, H. Franssen, J. Wokke, H. W. Van-es, . Van-den et al., Multifocal motor neuropathy: Diagnostic criteria that predict the response to immunoglobulin treatment, Ann Neurol. 1 déc, vol.48, issue.6, pp.919-945, 2000.